D Scarnecchia

Provided project oversight, cross-functional leadership, and coordination to successfully deliver updated version of Sentinel Common Data Model to FDA, including enhancement of internally developed software tools and successful upgrade of 14 external data partners - Served as coordinator for analyst team responsible for reviewing quality of data delivered by external partners - Served as project manager for team responsible for development and quality control of software used to query, analyze, and visualized electronic healthcare data

• Member, Data Science and Ethics Group (a nascent inter-agency working group focused on the risks posed to displaced persons by advanced data science, machine learning, and artificial intelligence) • Ethics Reviewer, Humanitarian Data Science Review • Freelance cartographic, network, and data visualizations for political risk clientele

Researched governance and management issues related to the use of ICTs and information in humanitarian response with a particular focus on standards and ethics, and the impact of technology on humanitarian crises and affected populations. - Investigated the safe, ethical, and rights-based use of digital ICTs and data in humanitarian settings through scholarly research and field assessments: - Co-authored a rights-based approach for assessing digital technology and data use during humanitarian crises, as well as the subsequent obligations necessary for humanitarian agencies to realize these rights - Developed an assessment template and capacity development curriculum to help organizations understand the scope of the digital technology use and associated risks - Created and facilitated workshops on the use of digital information and communication technologies for humanitarian practitioners - Engaged with internal and external stakeholders to support the Signal Program’s research aims: - Collaborated across institutions to help produce interdisciplinary work on topics ranging from GDPR compliance to the impact of disinformation on the Syria conflict - Facilitated workshops and panels on future technological threats to the humanitarian system - Promoted the Signal Program’s research through digital outreach, public speaking, and written communications - Designed promotional materials, including posters for speaking engagements and event invitations, as well as document layout for research reports - Held Signal Program corporate card, made team travel arrangements, and managed reimbursements per University guidelines

Developed strategies with pharmaceutical industry clients for the generation of real-world evidence for drug safety surveillance and health economics and outcomes research - Wrote landscape reports monitoring policy changes and industry trends and assessed the business impacts and opportunities of emerging technologies - Designed research frameworks, governance policies, and procedures for the creation of multi-stakeholder distributed research networks using real-world evidence to monitor drug safety and effectiveness - Convened industry, healthcare, academia, and government actors to build organizations which met the varied regulatory and business needs of stakeholders, including: • the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC), a $8M, multi-stakeholder distributed research network to monitor the safety and effectiveness of biologics and biosimilars • a three-year, $18M research plan for the Observational Medical Outcomes Partnership (OMOP) drug safety methods public private partnership